In a written Q&A with Science|Business, the ex-president of the European Research Council gives his reasons for leaving the post after only three months
Ursula von der Leyen promises reworked budget will provide forceful response to crisis, as she confirms fundraising event for vaccine research on May 4
The COVID-19 crisis has seen private investment in pre-market, high-risk start-ups dry up overnight. With no cash flow, they need support to stay afloat. The EIC Accelerator could be used to help them
The life science industry is all hands on deck in the race to develop vaccines, therapies and diagnostics in the fight against coronavirus. But while some prosper, many in the sector are forced to halt clinical trials and mothball labs
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.